Atypical and Serotonergic Antidepressants

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Serotonergic Cascade: Serotonin toxicity (Serotonin Syndrome) is driven by excessive central and peripheral serotonin (5-hydroxytryptamine [5-HT]) neurotransmission, predominantly via hyperstimulation of the 5-HT2A receptor subtype. This surge produces a distinct clinical triad: altered mental status, autonomic hyperactivity, and prominent neuromuscular hyperactivity.
• Atypical Mechanisms & Toxicity:
• Bupropion: Inhibits neuronal amine uptake. Uniquely, it induces a dose-dependent lowering of the seizure threshold, causing generalized seizures even at therapeutic levels, often without the profound CNS depression or initial QRS prolongation seen in other antidepressant classes.
• Citalopram/Escitalopram: Possess distinct cardiac channel-blocking properties that lead to QTc and QRS prolongation, separating them from other SSRIs.
• SNRIs (e.g., Venlafaxine): In massive overdose, these can trigger refractory hypotension and severe cardiac conduction delays.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Initial Resuscitation: Discontinue all serotonergic agents immediately. Ensure airway patency; severe central nervous system depression requires prompt intubation and mechanical ventilation.
• Targeted Pharmacotherapy:
• Agitation & Neuromuscular Hyperactivity: IV Benzodiazepines (e.g., diazepam 5–10 mg or lorazepam 1–2 mg IV, repeated every 10 minutes) are the cornerstone of therapy to halt seizures, blunt autonomic surges, and manage myoclonus.
• Hyperthermia: Initiate aggressive external cooling measures.
• Cardiovascular Instability:
• For severe hypertension: Use short-acting IV antihypertensives like nitroprusside or esmolol.
• For hypotension: Initiate rapid IV crystalloid fluids. If refractory, use direct-acting vasopressors (norepinephrine, epinephrine, or phenylephrine).
• For wide QRS: Administer Sodium Bicarbonate.
• For QTc prolongation / Torsades de Pointes: Administer IV Magnesium Sulfate.
• Decontamination: Administer single-dose activated charcoal (1 g/kg PO) only if the patient presents within 1 hour of ingestion, is awake, and can protect their airway. Consider whole-bowel irrigation specifically for massive (>4000 mg) venlafaxine overdoses.

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

• "Can't-Miss" Tox Mimics:
• Neuroleptic Malignant Syndrome (NMS): Shares fever, AMS, and autonomic instability, but features "lead-pipe" severe muscle rigidity and bradyreflexia, whereas Serotonin Syndrome presents with hyperreflexia, tremor, and myoclonus.
• Anticholinergic Toxicity: Presents with delirium and tachycardia but lacks diaphoresis; patients are "dry as a bone" and lack clonus.
• Sympathomimetic Overdose (Cocaine/Amphetamines): Causes extreme psychomotor agitation and hyperthermia but lacks the distinct spontaneous myoclonus of serotonin syndrome.
• Prioritized Diagnostic Workup:
• Serial ECGs: Mandatory to evaluate for QTc prolongation (Citalopram) or QRS widening.
• Metabolic & Muscle Panels: Check electrolytes, renal function, and creatine kinase (CK) to identify rhabdomyolysis generated by prolonged seizures or severe myoclonus.
• Co-Ingestant Screen: Always obtain an acetaminophen and salicylate level, as intentional overdoses frequently involve mixed agents.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

• The Toxic ECG Checklist:
• Interval Prolongation: Actively measure the QTc interval, as citalopram, escitalopram, and certain SNRIs are notorious for inducing marked QTc prolongation leading to Torsades de Pointes. Look for concurrent QRS widening indicating sodium channel blockade.
• Rhythm Analysis: Anticipate sinus tachycardia as the most common dysrhythmia. ECG abnormalities typically resolve gradually over 24 hours.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

• The Observation Guidelines:
• Immediate-Release Ingestions: Asymptomatic patients who have ingested immediate-release SSRIs or SNRIs must be observed on a continuous cardiac monitor for a minimum of 6 hours. If asymptomatic after 6 hours, they may be medically cleared for psychiatric disposition.
• Extended-Release Ingestions: Adult patients ingesting >450 mg of extended-release bupropion, or extended-release SSRI/SNRIs, require monitoring for at least 24 hours due to the high risk of delayed-onset seizures and toxicity.
• Admission Criteria: Any symptomatic patient (altered mental status, tachycardia, clonus) requires admission to a monitored bed or ICU.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

• Pitfall: Diagnosing NMS instead of Serotonin Syndrome and administering dopamine agonists. Critical Action: Strictly evaluate the patient's reflexes. The presence of hyperreflexia and clonus confirms Serotonin Syndrome; rigidity confirms NMS.
• Pitfall: Iatrogenic precipitation of Serotonin Syndrome in the ED. Critical Action: Never administer secondary serotonergic agents—such as tramadol, meperidine, or dextromethorphan—to a patient taking baseline SSRI/SNRI or MAOI therapy.
• Pitfall: Discharging a bupropion overdose prematurely. Critical Action: Extended-release bupropion can cause delayed, abrupt seizures well after the standard 6-hour window. Mandate a 24-hour observation.

7. MCQ MASTERCLASS (Written Exam Tips)

• Buzzword: "Myoclonus, spontaneous clonus in the lower extremities, and diaphoresis." Exam Answer: Serotonin Syndrome (myoclonus uniquely differentiates it from NMS).
• Buzzword: "Opsoclonus" (random, rapid, conjugate saccades of the eyes) in a hyperthermic patient. Exam Answer: Severe Serotonin Syndrome.
• Buzzword: "Seizures in an otherwise alert patient with no QRS prolongation." Exam Answer: Bupropion overdose.
• Distractor: An option suggests administering bromocriptine or dantrolene for a patient with hyperreflexia, hyperthermia, and diaphoresis. Correction: These are treatments for NMS or malignant hyperthermia. Serotonin syndrome is treated with IV benzodiazepines and cessation of the offending agent.
• High-Yield Fact: St. John's wort (Hypericum perforatum) is a non-selective serotonin reuptake inhibitor that can trigger severe Serotonin Syndrome when combined with other antidepressants.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

• The Rapid Differentiation: "The patient presents with marked hyperthermia, tachycardia, and altered mental status. On physical exam, I specifically note the presence of diaphoresis, hyperreflexia, and spontaneous myoclonus. This combination firmly establishes Serotonin Syndrome rather than Neuroleptic Malignant Syndrome, which would present with lead-pipe rigidity and bradyreflexia."
• The Medical Management: "I will immediately discontinue all suspected serotonergic medications. I am establishing IV access to administer a fluid bolus and push IV lorazepam to control the patient's severe agitation and myoclonus. I will initiate active external cooling measures."
• The Hemodynamic Escalation: "If the patient's severe hypertension persists, I will hang an esmolol or nitroprusside drip. Conversely, if they decompensate into refractory hypotension, I will strictly use direct-acting vasopressors like norepinephrine, avoiding indirect agents."